ketamine / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

98 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ketamine / Generic mfg.
ACTRN12621001127897p: Pilot study of ketamine in pyschogenic non-epileptic seizures.

Not yet recruiting
2
10
 
Department of Psychological medicine, Otago University , Otago Unverisity
Psychogenic non-epileptic seizures
 
 
ACTRN12621001127897: Pilot study of ketamine in pyschogenic non-epileptic seizures.

Not yet recruiting
2
10
 
Department of Psychological medicine, Otago University , Otago Unverisity
Psychogenic non-epileptic seizures
 
 
ACTRN12620000361909p: Ketamine and spider phobia replication study

Not yet recruiting
2
12
 
University of Otago, University of Otago
spider phobia
 
 
ACTRN12619001504101: Pilot study of ketamine in phobic participants using virtual reality stimuli

Not yet recruiting
2
12
 
University of Otago, University of Otago
spider phobia
 
 
ACTRN12620000361909: Ketamine and spider phobia replication study

Not yet recruiting
2
12
 
University of Otago, University of Otago
spider phobia
 
 
ACTRN12618001393246: Ketamine in anorexia nervosa

Not yet recruiting
2
24
 
University of Otago, University of Otago
anorexia nervosa, depressive disorder, anxiety disorder, obessional disorder
 
 
ACTRN12618001393246p: Ketamine in anorexia nervosa

Not yet recruiting
2
24
 
University of Otago, University of Otago
anorexia nervosa; depressive disorder; anxiety disorder; obessional disorder
 
 
ACTRN12622000245796: Ketamine assisted group mindfulness for alcohol use disorder

Not yet recruiting
2
80
 
University of Otago, University of Otago
Alcohol Use Disorder
 
 
ACTRN12622000245796p: Ketamine assisted group mindfulness for alcohol use disorder

Not yet recruiting
2
80
 
University of Otago, University of Otago
Alcohol Use Disorder
 
 
ACTRN12617001130358: A Study of Ketamine in Elderly Patients with Depression.

Recruiting
2
24
 
University of Otago, University of Otago
Depression
 
 
ACTRN12610001011077: Rapid depression treatment in cancer patients

Recruiting
2
50
 
University of Otago, University of Otago
Major depressive disorder, Cancer
 
 
ACTRN12621000528853: Ketamine for methamphetamine use in young people

Recruiting
2
20
 
Orygen National, National Centre for Clinical Research on Emerging Drugs (NCCRED)
Methamphetamine use problems
 
 
ACTRN12623000594628: Assessing the feasibility and benefits of Ketamine Sedation in Acute Brain Injury

Recruiting
2
40
 
Alfred Health , Alfred Research Trusts
Traumatic Brain Injury
 
 
2015-000142-29: / Kétamine et douleur neuropathique

Ongoing
2
22
Europe
KETAMINE, SULFATE DE MAGNESIUM, Injection, Kétamine, SULFATE DE MAGNESIUM
CHU CLERMONT-FERRAND, CHU CLERMONT-FERRAND
/ Patient souffrant de douleur neuropathique, / Patient souffrant de douleur neuropathique, Diseases [C] - Nervous System Diseases [C10]
 
 
2006-006445-13: Programme de réhabilitation précoce dans les Néphrectomie totales pour cancer du rein

Ongoing
2
70
Europe
Neurontin, Ketamine, Naropeine, Neurontin, Ketamine, Naropeine
Centre hospitalier Régional et Universitaire
 
 
2008-004002-14: pharmacokinetic-pharmacodynamic modeling of S(+)-ketamine in fibromyalgia

Ongoing
2
12
Europe
Intravenous infusion
TREND
subjects suffer from fibromyalgia
 
 
2011-003654-40: A study to see if the medication Ketamine can relieve depression in people who have not responded to another class of medication called Selective Serotonin Re-uptake Inhibitors (SSRIs)

Ongoing
2
20
Europe
ketalar, ketalar
Department of Psychiatry, Department of Psychaitry
Depression
 
 
2013-002012-27: Ketamine dose finding study in pediatric burn wound care Ketamindossökande studie för pediatrisk brännskadevård

Ongoing
2
60
Europe
Ketamine,
LANDSTINGET I ÖSTERGÖTLAND, LIO Sinnescentrum
Pediatric burn patients who need rectal sedation during wound care Brännskade barn som behöver rektal sedering under sårvård.
 
 
2016-001715-21: Ketamine for depression

Ongoing
2
120
Europe
Infusion, Ketamine (Ketalar by Pfizer)
UZ Leuven, IWT Agentschap voor Innovatie door Wetenschap en Technologie
Major depressive disorder and Bipolar Disorder I and II, depression, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
2020-004487-25: Experiencing the self through touch - self-other-distinction in an altered state of self: An exploratory randomized placebo-controlled experimental medicine study

Not yet recruiting
2
30
Europe
Concentrate for solution for injection, Ketamine
Linköpings Universitet, Swedish Research Council
Healthy volunteer., Healthy volunteer., Not possible to specify
 
 
ACTRN12618001586202: Low dose individually-tailored subcutaneous ketamine infusion for the treatment of depression in palliative care patients

Terminated
2
32
 
University of Technology Sydney, Sacred Heart Hospital, Calvary Hospital, Braeside Hospital, Liverpool Hospital
Major Depressive Disorder, Advanced life limiting illnesses
 
 
2018-003421-28: Ketamine interleaved with electroconvulsive therapy for depression, a pragmatic randomised controlled pilot trial (KITE-Dep)

Not yet recruiting
2
24
Europe
Ketalar 10mg/ml Solution for injection, Hypnovel 10mg/5ml solution for injection, N01AX03, Solution for injection/infusion, Solution for infusion, Ketalar, Hypnovel 10mg/5ml solution for injection
St Patrick's Mental Health Services, none
Depression, Depression, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
2020-005037-32: Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer. Psilocybin – strategie rychlé antidepresivní odpovědi u deprese komorbidní s onkologickým onemocněním.

Not yet recruiting
2
60
RoW
Psilocybine, ketamine hydrochloride, MIDAZOLAM, Capsule, hard
Národní ústav duševního zdraví, Národní ústav duševního zdraví
Depressive disorder comorbid with cancer Depresivní porucha komorbidní s onkologickým onemocněním, Depressive disorder accompanying cancer Depresivní porucha provázející onkologické onemocnění, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
CIVIK, NCT03362073: Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients

Recruiting
2
26
RoW
Ketamine
Pusan National University Yangsan Hospital
Ketamine, Refractory Cancer Pain
12/21
12/21
2021-000041-40: A study to investigate the effects of repeated low doses of psilocybin and ketamine on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action

Not yet recruiting
2
34
Europe
Psilocybin, Ketamine, Capsule
Maastricht University, Silo Pharma Inc.
Parkinson's disease, Parkinson's disease, Diseases [C] - Nervous System Diseases [C10]
 
 
NCT04275661: Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery

Active, not recruiting
2
60
RoW
Ultrasound (US) bi-level erector spinae block, levobupivacaine, Ketamine, Magnesium Sulfate
Assiut University
Analgesia, Breast Cancer
03/22
04/22
2021-002321-23: Ketamine to treat patients with post-comatose disorders of consciousness

Not yet recruiting
2
40
Europe
Ketamine, Infusion, Ketalar
University of Liège, University of Liege, Fonds Léon Fredericq, Fonds de la Recherche Scientifique – FNRS
Disorders of consciousness as Unresponsive Wakefulness Syndrome (UWS) and Minimally Conscious State (MCS) after a coma due to acquired brain injury. Patients who emerged from the minimally conscious state (EMCS), Disorders of consciousness Troubles de l'état de conscience, Diseases [C] - Nervous System Diseases [C10]
 
 
2022-001997-70: Efficacy of ketamine to prevent relapse in opioid addicts

Ongoing
2
60
RoW
Ketamin Inresa 10 ml Solution for injection 500 mg 50 mg/ml, Solution for injection, Ketamin Inresa 10 ml Solution for injection 500 mg 50 mg/ml
University of Cyprus, Research and Innovation Foundation
Methadone and buprenorphine comprise a first-line, evidence-based opioid substitution treatment (OST) for OUD patients. Unfortunately, retention and adherence to OST treatment is currently a major challenge in the treatment of OUDs. Another major challenge for opioid addicts who are recovering from addiction is the maintenance of a drug-free state due to the negative affect associated with protracted opioid abstinence, including depression, anhedonia, and anxiety., Opioid addiction is a chronic, relapsing brain disorder causing high rates of mortality, primarily due to overdose incidences., Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
NCT04220489: Perioperative Ketamine in Opioid-Tolerant Patients Undergoing Lumbar Spine Surgery

Terminated
2
1
US
Ketamine, Ketalar, Placebo Comparator, Placebo Group
Jacques E. Chelly
Opioid Dependence, Chronic Pain
11/22
11/22
NCT04658420: A Single Ketamine Infusion Combined With Music for Suicidal Ideation

Not yet recruiting
2
200
US
Ketamine Hydrochloride, Ketamine, Music
The University of Texas Health Science Center at Tyler, National Institutes of Health (NIH), The University of Texas Health Science Center, Houston
Suicidal Ideation, Depressive Episode
12/22
04/23
NCT04724759: The Effect of Opioid-Free Anesthesia in TMJ Surgery

Recruiting
2
60
US
Dexmedetomidine / Ketamine / Lidocaine, Precedex
Massachusetts General Hospital
Temporomandibular Joint Disorders
12/22
07/23
NCT05294835: Ketamine and Epigenetic Aging

Recruiting
2
20
US
Ketamine
TruDiagnostic, Wild Health
Depression, Post Traumatic Stress Disorder
12/22
12/22
NCT04177706: Ketamine for the Treatment of Opioid Use Disorder and Depression

Completed
2
21
US
Ketamine Hydrochloride, Placebo
Medical University of South Carolina, National Institute on Drug Abuse (NIDA)
Depression, Opioid-use Disorder, Opioid Abuse
11/22
11/22
KReDO, NCT05193318: KAP for Depression in Abstinent Opioid Users

Terminated
2
5
US
Ketamine-assisted psychotherapy
Medical University of South Carolina
Opioid Use Disorder, Severe, in Sustained Remission, Opioid Use Disorder, Severe, in Early Remission, Major Depressive Disorder
03/23
03/23
2021-004927-34: Clinical study to investigate the efficacy, safety and tolerability of the test substance Ketamine hydrochloride prolonged release tablets compared to placebo in patients with treatment resistant depression.

Not yet recruiting
2
180
Europe, RoW
Ketamine Hydrochloride Prolonged Release Tablets, KET01, Prolonged-release tablet
Ketabon GmbH, Ketabon GmbH
Treatment-resistant depression, Treatment-resistant depression is defined as the intake of 2 different anti-depressant medications for a sufficient length of time at an adequate dose without an adequate improvement of the depression, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
MKET, NCT02624596: Understanding How Ketamine Brings About Rapid Improvement in OCD

Active, not recruiting
2
120
US
Ketamine, Ketamine Hydrochloride, Midazolam, Midazolam Hydrochloride
Stanford University, University of Connecticut
Obsessive-Compulsive Disorder
06/25
06/25
NCT03336398: Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus

Completed
2
42
US
Ketamine Hydrochloride in saline, Ketamine HCI, Saline, Saline solution
New York State Psychiatric Institute
Tinnitus
06/23
07/24
NCT05663801: Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy

Not yet recruiting
2
72
RoW
Use of Bupivacaine in pectoral nerve block in mastectomy, marcain, use of Ketamine as adjuvants to bupivacaine in pectoral nerve block in mastectomy, ketalar, Use of Magnesium Sulfate as adjuvants to bupivacaine in pectoral nerve block in mastectomy, Mgso4
Beni-Suef University
Cancer, Breast
09/23
10/23
NCT04889664: Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD

Completed
2
16
US
Ketamine, Written Exposure Therapy, WET
Icahn School of Medicine at Mount Sinai
PTSD
07/23
10/23
NCT05690503: Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

Active, not recruiting
2
12
US
CI-581a, CI-581b
New York State Psychiatric Institute
Post-acute Sequelae of COVID-19, Depressive Symptoms, Cognitive Dysfunction
06/25
12/25
KRF-EOL, NCT05214417: Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy

Not yet recruiting
2
120
NA
Ketamine Injectable Solution, Naturalistic Control
The Ketamine Research Foundation
Illness Terminal
01/24
03/24
Ket-CBT, NCT06480500: i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

Recruiting
2
110
Canada
Ketamine hydrochloride, i-CBT (Internet-based Cognitive Behavioural Therapy), Midazolam Hydrochloride
University Health Network, Toronto, Ontario Shores Centre for Mental Health Sciences
Major Depressive Disorder, Suicide, Treatment Resistant Depression
04/25
07/25
NCT04771767: Combined Ketamine and eCBT Intervention for PTSD

Recruiting
2
16
Canada
Ketamine, Ketalar, Online Trauma-Focused Cognitive Behavioural Therapy, eCBT, TF-CBT
Queen's University
Post-Traumatic Stress Disorder
03/24
03/24
KET-BD, NCT05004896: Ketamine for Treatment-Resistant Bipolar Disorder

Recruiting
2
100
Canada
Ketamine Hydrochloride, Midazolam Hydrochloride
Joshua Rosenblat
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder
04/25
12/25
NCT05019885: The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy

Recruiting
2
8
US
Ketamine Hydrochloride
Madeline Fields
Drug Resistant Epilepsy, Medically Refractory Epilepsy, Refractory Epilepsy
12/24
12/24
Ket+CBASP, NCT06410599: Pharmacologic Treatment Augmentation in Chronic Depression

Not yet recruiting
2
60
Europe
Ketamine, Ketamine hydrochloride (Ketamin Inresa 2 ml), Placebo, Saline solution: Fresenius Kabi Deutschland GmbH Isotone E NaCL 0.9 %, CBASP, Cognitive Behavioral Analysis System of Psychotherapy, TAU, Treatment as usual
University Hospital Tuebingen, German Center for Mental Health
Major Depressive Disorder
05/26
07/26
KET-BD-Sustain, NCT05339074: Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression

Recruiting
2
60
Canada
Ketamine Hydrochloride
Joshua Rosenblat
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder
08/25
02/26
2020Ketamine, NCT04600089: Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI

Recruiting
2
20
US
Saline, Ketamine
Sam Tyagi
Descending Aortic Dissection, Postoperative Pain, Thoracoabdominal Aortic Aneurysm
08/24
08/24
KET-PD, NCT04944017: Ketamine for the Treatment of Depression in Parkinson's Disease

Recruiting
2
56
US
Ketamine Infusion, Placebo - Saline Infusion
Yale University, Fox (Michael J.) Foundation for Parkinson's Research
Parkinson's Disease, Depression
08/24
08/24
Psi vs Ket, NCT06405607: Psilocybin vs Ketamine for Alcohol Use Disorder

Not yet recruiting
2
80
NA
Psilocybin, Ketamine
University of Iowa
Alcohol Use Disorder, Alcohol Dependence, Alcohol Abuse
06/27
06/27
NCT05661669: Ketamine for the Treatment for Alcohol Use Disorder in the ED

Withdrawn
2
50
US
Ketamine, Saline
Brigham and Women's Hospital, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcohol Use Disorder
06/24
06/24
NCT02122562: Ketamine Alcohol (in Treatment-Resistant Depression)

Recruiting
2
60
US
Ketamine
Mark Niciu, National Institute of Mental Health (NIMH)
Magnetic Resonance Imaging, Major Depression, Alcoholism
09/26
09/26
NCT06419985: Ketamine HCl Prolonged Release Oral Tablets for CRPS

Not yet recruiting
2
50
US
80mg Ketamine HCl Prolonged Release, 80mg Ketamine PR, 160mg Ketamine HCl Prolonged Release, 160mg Ketamine PR, Administration of Ketamine HCl Prolonged Release - 240mg, 240mg Ketamine PR
University of Southern California
Complex Regional Pain Syndromes
01/26
07/26
KMD, NCT06496750: Ketamine for Methamphetamine Use Disorder

Recruiting
2
120
US
Ketamine Hydrochloride, Ketelar, Midazolam Hydrochloride, Versed
University of Texas Southwestern Medical Center
Substance Use Disorders, Substance Use, Methamphetamine Abuse
02/27
04/27
NCT05421065: Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder

Recruiting
2
20
US
Psilocybin, Ketamine
Peggy C Nopoulos
Alcohol Use Disorder
01/25
02/25
KAP, NCT06559826: Ketamine-Assisted Psychotherapy () Compared to Ketamine Alone for the Treatment of Depression

Recruiting
2
70
US
Ketamine, Psychotherapy
Icahn School of Medicine at Mount Sinai
Major Depressive Disorder
08/27
08/27
NCT06608277: Ketamine, SGB and Combination Treatment for TBI

Not yet recruiting
2
175
US, RoW
Group A active comparator, Group A, Group B active comparator, Group B, Group C Experimental, Group C, Group D Placebo Comparator, Group D
Northwestern University, Walter Reed National Military Medical Center, Lviv National Medical University
Posttraumatic Headache, Posttraumatic Stress Disorder
12/27
04/28
NCT05803551: A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients

Not yet recruiting
2
50
US
Ketamine Hydrochloride, Ketalar, Placebo
Mayo Clinic
Depression
12/25
12/26
KetaMet, NCT06538285: Ketamine Therapy for Methamphetamine Use Disorder & HIV

Not yet recruiting
2
12
US
Ketamine, Ketalar, Ketamine hydrochloride, Ketamine injection, Psychotherapy, Talk therapy, Therapy
Nicky Mehtani, MD, MPH, San Francisco Department of Public Health, California HIV/AIDS Research Program, National Center for Advancing Translational Sciences (NCATS)
Methamphetamine Use Disorder
11/25
04/26
KPD, NCT06231563: Ketamine for Veterans With Parkinson's Disease

Not yet recruiting
2
80
US
Ketamine, Remimazolam
VA Office of Research and Development
Parkinson's Disease
06/29
06/29
NCT06111339: Ketamine for OUD and Suicidal Ideation in the ED

Recruiting
2
50
US
Ketamine, Saline Solution
Brigham and Women's Hospital
Opioid Use Disorder, Suicidal Ideation
03/25
05/25
PSIKET_001, NCT05383313: Psilocybin Versus Ketamine in Treatment-Resistant Depression

Recruiting
2
60
RoW
Psilocybin, Ketamine Hydrochloride, Midazolam Ph. Eur 9.0
National Institute of Mental Health, Czech Republic, Czech Health Research Council, Czech Clinical Research Infrastructure Network
Treatment Resistant Depression
04/25
04/25
NCT02543983: Neurobiology of Suicide

Recruiting
2
325
US
Magnetic Resonance Imaging scanner, 3T, NeurOptics PLRTM-3000 Pupillometer, Experimental Anxiety Devices, Magnetic Resonance Imaging scanner, 7T, Ketamine Hydrochloride
National Institute of Mental Health (NIMH)
Healthy Volunteers, Depression
07/25
07/25
Co-Boost, NCT06125054: Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction

Recruiting
2
120
Europe
Ketamine, Placebo, 0.9% saline solution, real-time fMRI neurofeedback training, sham real-time fMRI neurofeedback training
Dr. med. Marcus Herdener, University of Zurich, University of Vienna, University of Campania "Luigi Vanvitelli"
Cocaine Use Disorder, Cocaine Dependence
12/25
03/26
NCT06069843: Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment

Recruiting
2
15
US
IV Ketamine
Icahn School of Medicine at Mount Sinai
Depression, Mild Cognitive Impairment
09/25
09/25
NCT06419439: Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression

Not yet recruiting
2
44
US
Ketamine hydrochloride, Minimally Enhanced Usual Care, Control, Brief narrative intervention, Active/intervention
VA Office of Research and Development
Chronic Low Back Pain, Depression
12/28
06/29
PT2PC, NCT05403086: Pragmatic Trial of Psilocybin Therapy in Palliative Care

Not yet recruiting
2
100
NA
Psilocybin, Hallucinogen, Ketamine, Ketalar
Charles S. Grob, M.D., University of California, San Francisco
Demoralization
12/25
03/26
UNIKET, NCT05046184: Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets

Recruiting
2
180
US
Ketamine Hydrochloride, Midazolam injection
University of Texas Southwestern Medical Center
Major Depressive Disorder, Healthy Controls
08/26
11/26
MKET2, NCT05940324: Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD

Recruiting
2
150
US
Ketamine, Ketamine Hydrochloride, Ketalar, Naltrexone Pill, Naltrexone, Placebo pill
Stanford University, National Institute of Mental Health (NIMH)
Obsessive-Compulsive Disorder
11/28
11/28
NCT05786066: The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

Recruiting
2
30
US
Perampanel 6 MG, Ketamine, Placebo
Yale University, American Foundation for Suicide Prevention, National Center for PTSD, VA Connecticut Healthcare System
Depressive Disorder, Major Depressive Disorder, Bipolar Disorder, Post Traumatic Stress Disorder, Suicidal Ideation
03/33
03/33
ACTRN12623000061639: A Phase 1, Single Centre, Randomized, Double Blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of NeuroDirect Ketamine in Healthy Adult Volunteers

Not yet recruiting
1/2
24
 
Psycheceutical, Inc, Psycheceutical, Inc
Post-traumatic stress disorder
 
 
ACTRN12621000119897p: Effect of ketamine and brain stimulation on tinnitus loudness and distress

Not yet recruiting
1/2
24
 
Dirk De Ridder, University of Otago
Tinnitus
 
 
ACTRN12617001177347: Evaluation of brain glutamatergic mechanisms in patients with treatment resistant anxiety

Not yet recruiting
1/2
40
 
University of Otago, University of Otago
Anxiety
 
 
ACTRN12617001177347p: Evaluation of brain glutamatergic mechanisms in patients with treatment resistant anxiety

Not yet recruiting
1/2
40
 
University of Otago, University of Otago
Anxiety
 
 
ACTRN12619000311156p: Ketamine and Internalizing Disorders

Not yet recruiting
1/2
48
 
University of Otago, Otago Medical Research Foundation
Depression; Post-Traumatic Stress Disorder; Obsessive-Compulsive Disorder; Phobic Disorders
 
 
ACTRN12620000117910: Nasal spray ketamine/dexmedetomidine for pain relief

Recruiting
1/2
30
 
Monash Medical Centre, Monash Medical Centre
Analgesia
 
 
ACTRN12611001109998: Evaluation of the analgesic effects of ketamine and fentanyl as an Additive to Intrathecal bupivacaine in patients undergoing cesarean section

Recruiting
1/2
90
 
Qazvin University of Medical Science., Marzieh Beigom Khezri
post-operative pain in Patients undergoing cesarean section
 
 
ACTRN12610000658011: Comparison of peritonsillar infiltration of ketamine and dexamethason for postoperative pain relief in children following adenotonsillectomy

Recruiting
1/2
160
 
Qazvin University of Medical Science., Marzieh Beigom Khezri,
postoperative pain after tonsillectomy
 
 
ACTRN12619000311156: Ketamine and Internalizing Disorders

Recruiting
1/2
48
 
University of Otago, Otago Medical Research Foundation
Depression, Post-Traumatic Stress Disorder, Obsessive-Compulsive Disorder, Phobic Disorders
 
 
ACTRN12621000119897: Effect of ketamine and brain stimulation on tinnitus loudness and distress

Recruiting
1/2
24
 
Dirk De Ridder, University of Otago
Tinnitus
 
 
NCT04686448: Ketofol Versus Fenofol as Procedural Sedation for Carpal Tunnel Release

Recruiting
1/2
56
RoW
propofol-ketamine, ketofol, propofol-fentanyl, fenofol
Zagazig University
Procedural Sedation
04/21
05/21
2021-002604-12: The effect of ketamine on aesthetics and role for antidepressant effects Einfluss von Ketamin auf ästhetische Prozesse und Relevanz für antidepressive Effekte

Not yet recruiting
1/2
65
Europe
Ketamin hameln, 32265.00.00, Solution for injection/infusion, Ketamin-hameln
Medical University of Vienna, Medical University of Vienna, Interdisciplinary Cluster Project
Depression Depression, Depression Depression, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
KODIAC, NCT04471818: Ketamine or Placebo in Patients With Major Depression and Advanced Cancer

Completed
1/2
19
RoW
Ketamine, Placebo
Instituto Nacional de Cancerologia de Mexico
Major Depressive Disorder, Advanced Cancer
06/23
07/23
NCT04916548: Repeated Neurocognitive Measurements in Depressed Patients

Completed
1/2
15
US
Intravenous Ketamine
Rebecca Price
Depression, Unipolar
07/23
08/23
NCT05168735: Ketamine + Mindfulness for Depression

Completed
1/2
43
US
Intravenous Ketamine, Brief Mindfulness Exercises, Academic Exercises
Rebecca Price
Depression, Unipolar
08/23
09/23
NCT04621526: Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma

Completed
1/2
56
RoW
dexmedetomidine- ketamine, precedex- katalar, dexmedetomidine- propofol, precedex- diprivan
Zagazig University
Conscious Sedation
08/23
08/23
NCT02461927: Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Completed
1/2
65
US
Ketamine + Naltrexone, Ketamine + Placebo, Placebo (psychoactive placebo midazolam) + Placebo
VA Office of Research and Development
Major Depressive Disorder, Alcohol Use Disorder
10/23
10/23
NCT04892251: Ketamine Assisted Psychotherapy for Opioid Use Disorder

Recruiting
1/2
60
US
MORE+KAP, MORE
University of Utah
Opioid-use Disorder
12/23
05/24
TIVA, NCT06031883: Efficacy of Adding Low Dose Ketamine or Fentanyl to Propofol-dexmedetomidine as Total Intravenous Anesthesia

Recruiting
1/2
40
RoW
Ketamine, Fentanyl
Minia University, Minia University Hospital
Patients Undergoing Elective Craniotomy
04/24
04/24
NCT06077539: Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics

Recruiting
1/2
100
RoW
Dexmedetomidine, Ketamine, Magnesium, normal saline 0.9% NaCL
Cairo University
Anesthesia Emergence Delirium
04/24
05/24
CONCHKAP, NCT06036511: Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD

Withdrawn
1/2
14
US
Ketamine Hydrochloride, KAP
University of New Mexico, The Mind Research Network
PTSD
12/23
12/23
NCT06545890: Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries

Recruiting
1/2
46
RoW
Ketamine, propofol, Dexmedetomidine
Cairo University
Emergence Delirium
11/24
11/24
NCT06490731: Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients

Not yet recruiting
1/2
2
NA
Dexmedetomidine, Ketamine
New Valley University
Haemodynamic Rebound
08/25
01/26
NCT04955470: Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics

Recruiting
1/2
96
Canada
Ketamine Injectable Solution, Midazolam Injectable Solution, Normal Saline 0.9% Injectable Solution
University of British Columbia
Suicidal Ideation
11/24
12/24
NCT04589208: Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)

Suspended
1/2
35
US
Ketamine Hydrochloride
New York State Psychiatric Institute, National Institute of Mental Health (NIMH)
Healthy
12/25
02/26
NCT05156060: Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

Recruiting
1/2
44
US
Gabapentin, Neurontin, Ketamine, Ketalar
Natalie Lockney
Head and Neck Cancer, Locally Advanced Head and Neck Carcinoma
12/25
12/26
NCT05991232: Repeated Neurocognitive Measurements in Depressed Patients

Not yet recruiting
1/2
20
NA
Intravenous Ketamine, Ketalar
Jay Fournier
Depression, Unipolar
11/25
12/25
KeDA, NCT06090422: Ketamine for Combined Depression and Alcohol Use Disorder

Not yet recruiting
1/2
34
NA
Ketamine Hydrochloride, Midazolam Hydrochloride
University Hospital of North Norway, University of Exeter
Depression, Alcohol Use Disorder
07/27
07/27

Download Options